title: Approaches to implement bispecific antibody treatment of ovarian carcinoma.
authors.affiliation: Division of Experimental Oncology E, Istituto Nazionale Tumori, Milan, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Canevari
authors.forename: D
authors.initials: D
authors.lastname: Mezzanzanica
authors.forename: A
authors.initials: A
authors.lastname: Mazzoni
authors.forename: D R
authors.initials: DR
authors.lastname: Negri
authors.forename: M
authors.initials: M
authors.lastname: Figini
authors.forename: V
authors.initials: V
authors.lastname: Ramakrishna
authors.forename: G
authors.initials: G
authors.lastname: Bolis
authors.forename: M I
authors.initials: MI
authors.lastname: Colnaghi
mesh_terms: D018033:Antibodies, Bispecific / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D018106:CD28 Antigens / Q000276:immunology; D017252:CD3 Complex / Q000276:immunology*; D002352:Carrier Proteins / Q000276:immunology*; D005260:Female; D058973:Folate Receptors, GPI-Anchored; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008213:Lymphocyte Activation / Q000276:immunology; D010051:Ovarian Neoplasms / Q000276:immunology / Q000628:therapy*; D011956:Receptors, Cell Surface; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D018033:Antibodies, Bispecific; D018106:CD28 Antigens; D017252:CD3 Complex; D002352:Carrier Proteins; D058973:Folate Receptors, GPI-Anchored; D011956:Receptors, Cell Surface